ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,937 | -21.9% | 5,775 | -11.2% | 0.11% | -34.7% |
| Q4 2022 | $263,640 | +22.6% | 6,500 | 0.0% | 0.17% | +8.3% |
| Q3 2022 | $215,000 | -6.1% | 6,500 | 0.0% | 0.16% | -1.9% |
| Q2 2022 | $229,000 | -23.7% | 6,500 | -0.4% | 0.16% | -10.1% |
| Q1 2022 | $300,000 | -30.7% | 6,525 | 0.0% | 0.18% | -19.8% |
| Q4 2021 | $433,000 | +10.2% | 6,525 | +3.7% | 0.22% | +11.0% |
| Q3 2021 | $393,000 | +293.0% | 6,295 | +79.9% | 0.20% | +110.5% |
| Q1 2020 | $100,000 | -55.9% | 3,500 | -2.5% | 0.10% | -58.1% |
| Q4 2019 | $227,000 | – | 3,591 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |